Publication:
SOX4 Expression Levels in Urothelial Bladder Carcinoma

dc.authorscopusid6603432100
dc.authorscopusid55788627100
dc.authorscopusid22945639700
dc.authorscopusid6602191291
dc.authorscopusid6603857296
dc.contributor.authorGüneş, S.
dc.contributor.authorYeǧin, Z.
dc.contributor.authorSüllü, Y.
dc.contributor.authorBüyükalpelli, R.
dc.contributor.authorBaǧci, H.
dc.date.accessioned2020-06-21T14:46:27Z
dc.date.available2020-06-21T14:46:27Z
dc.date.issued2011
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Güneş] Sezgin Özgür, Department of Medical Biology and Genetics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Yeǧin] Zeynep, Department of Medical Biology and Genetics, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Süllü] Yurdanur Demirel, Department of Pathology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Büyükalpelli] Recep, Department of Urology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Baǧci] Hasan, Department of Medical Biology and Genetics, Ondokuz Mayis Üniversitesi, Samsun, Turkeyen_US
dc.description.abstractHigh levels of SOX4 gene expression have been reported in a variety of human cancers. The protein may function in the apoptosis pathway, leading to cell death as well as to tumorigenesis. The aim of this study was to investigate the levels of SOX4 expression in bladder cancer. Urinary bladder tumor samples were obtained from 57 bladder cancer and 13 normal bladder biopsies. The levels of SOX4 expression in bladder cancer were determined by immunohistochemistry and real-time PCR. SOX4 gene expression was increased 2.2 times in bladder tumors as compared with normal tissue. The presence of protein was confirmed by immunostaining. There were significant differences between immunostaining of bladder tumors and normal bladder tissue (P= 0.001). The present data suggest that SOX4 gene may have a role in bladder cancer tumorigenesis. © 2011 Elsevier GmbH.en_US
dc.identifier.doi10.1016/j.prp.2011.05.005
dc.identifier.endpage427en_US
dc.identifier.issn0344-0338
dc.identifier.issn1618-0631
dc.identifier.issue7en_US
dc.identifier.pmid21680105
dc.identifier.scopus2-s2.0-79959716767
dc.identifier.scopusqualityQ3
dc.identifier.startpage423en_US
dc.identifier.urihttps://doi.org/10.1016/j.prp.2011.05.005
dc.identifier.volume207en_US
dc.identifier.wosWOS:000293497000004
dc.identifier.wosqualityQ2
dc.language.isoenen_US
dc.publisherElsevier GmbH, Urban & Fischer Verlagen_US
dc.relation.ispartofPathology Research and Practiceen_US
dc.relation.journalPathology Research and Practiceen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBladder Carcinomaen_US
dc.subjectGene Expressionen_US
dc.subjectSOX4 Geneen_US
dc.titleSOX4 Expression Levels in Urothelial Bladder Carcinomaen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files